nonracemic amisulpride engineered higher binding affinity receptor lower affinity receptor compared conventional racemic contains r senantiomers amisulpride ratio rather ratio modification hoped give compound improved efficacy fewer side development treatment depression people bipolar disorder approved would first amisulpride approved us psychiatric phase iii trial pharmacologyrelated article stub help wikipedia expanding